Shimrit Uliel Siboni
- 4.5 Buono • 156 recensioni
- 29 anni di esperienza
- Israele, Tel Aviv-Giaffa, Sourasky Medical Center (Ichilov)
Con oltre 30 anni di esperienza, il medico è specializzato in disturbi neurologici, concentrandosi sulla malattia di Parkinson e il parkinsonismo. Il medico dirige l'Unità di Neurologia presso il Sourasky Medical Center e ha diretto l'Unità Disturbi del Movimento. Il medico ha collaborato con la Michael J Fox Foundation ed è stato professore e ricercatore ospite in istituzioni prestigiose come l'Università Radboud e l'Università di Oxford.<\/p>
Educato presso l'Università Ben-Gurion e l'Università di Tel Aviv, il medico ha completato una borsa di studio in Disturbi del Movimento presso la Columbia University. Il medico ha pubblicato oltre 200 articoli scientifici e ha ricevuto premi per l'eccellenza nell'assistenza medica e nell'insegnamento.<\/p>
Il dottore è un neurologo ed epilettologo con 25 anni di esperienza. Ha ricevuto la sua formazione presso l'Università di Washington e il Barnes-Jewish Center for Comprehensive Epilepsy negli USA.<\/p>
Il medico è un neurochirurgo altamente qualificato con vasta esperienza nel campo della chirurgia cerebrale e nervosa. Specializzandosi in disturbi neurologici complessi, il medico ha eseguito con successo numerosi interventi chirurgici complessi, contribuendo in modo significativo ai progressi nelle tecniche neurochirurgiche. Il medico è certificato e ha ricevuto numerosi riconoscimenti per l'eccellenza nella cura del paziente e nella ricerca innovativa. Con un impegno per l'educazione, il medico tiene frequentemente conferenze a congressi internazionali e ha pubblicato ampiamente in riviste peer-reviewed.<\/p>
Il medico è affiliato alla Scuola di Medicina Sackler presso l'Università di Tel Aviv.<\/p>
Il medico è un neurochirurgo esperto con oltre 49 anni al Sourasky Medical Center, specializzato in malattie cerebrali come l'epilessia.<\/p>
Laureato all'Università di Tel Aviv, il medico ha completato un tirocinio presso il Centro Medico Sheba e una residenza in neurologia presso il Centro Medico Beilinson.<\/p>
Ulteriore formazione ha incluso tirocini in elettroencefalografia ed elettromiografia presso la Mayo Clinic, e una residenza in neurologia presso il Centro Medico di Tel Aviv.<\/p>
Il medico è membro di diverse organizzazioni professionali, tra cui l'Associazione Medica Israeliana e la Società Americana di Neurologia.<\/p>
Il medico si è laureato presso l'Università di Stanford e ha completato ulteriori studi presso l'Università di Yale. Specializzandosi in interventi chirurgici avanzati al cervello per bambini e adulti, il medico si concentra sul trattamento dell'epilessia, comprese le interventi chirurgici, la stimolazione cerebrale profonda e la mappatura funzionale del cervello. Il medico è anche coinvolto nel trattamento delle malformazioni vascolari legate all'epilessia.<\/p>
Il medico ha fatto scoperte scientifiche significative, tra cui approcci innovativi per studiare le crisi epilettiche, nuovi metodi per recuperare i disturbi del linguaggio e della memoria secondari all'epilessia, e programmi moderni per la gestione dei pazienti epilettici. Il medico pratica presso l'Ospedale Ichilov e insegna presso la David Geffen School of Medicine presso UCLA, l'Università di Yale e il Centro Medico di Tel Aviv.<\/p>
Prof. Dr. Yasef began his medical education at Istanbul University in 1973 and graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1979. He started his specialization in neurology at the same university in 1980 and became a neurologist in 1985. During his specialty training, he spent 6 months at Hacettepe University in the Neurology Department in Ankara.
After becoming a neurologist, he completed 3.5 years of obligatory government service, spending the first 1.5 years at the Iskenderun Navy Hospital and the next 2 years at Diyarbakır Social Security Hospital. He returned to Istanbul University in 1989.
Prof. Dr. Yasef worked abroad in the United States from 1990 - 1991, focusing on dementia and behavioral neurology.
In 1994, he became an Associate Professor and continued working at Istanbul University until 1999. Between 1999 - 2002, he worked at Florence Nightingale Hospital, and then at Kozyatağı Acıbadem Hospital from 2004 to 2013.
Since 2013, he has been a valuable part of the team at Florence Nightingale Hospital.
Specialties
Work Experience
Responsabile dell'Unità Avanzata di Neuroscienze presso Quirónsalud – il Dr. Torres è specializzato in epilessia e diagnosi neurologiche complesse.
Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.
More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.
The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.
Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.
He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).
Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.
In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.
In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).
Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.
Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.
Professional experience
Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.
Membership in scientific societies
National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)
President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).
Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).
Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).
Research and Teaching
Principal investigator of 100 national and international clinical trials.
7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).
10 projects from private foundations, received on a competitive basis (7 as principal investigator).
He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).
His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.
Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.
Education :
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Dr Romero Imbroda is an academic of the Royal Academy of Medicine of Eastern Andalusia and a Fellow of the European Board of Neurology, as well as a Member of the Board of Directors of the
Andalusian Society of Neurology. He combines his medical practice with his teaching role at the University of Granada, where he is a Lecturer and has been a Member of the Internal Residential Doctor Assessment Committee in Melilla until 2017.
He is the author of several national and international scientific publications. He has also participated in research projects associated with treatments for multiple sclerosis.
Professional Experience:
• 2020: President of the Andalusian Society of Neurology
• 2019: Head of the Units at the Quirónsalud Malaga and Marbella Hospitals
• 2017-2021: Neurologist at the Regional Malaga University Hospital.
• 2016-2017: Lecturer at the University of Granada.
• 2009-2017: Neurologist at the Imbrain Neuroscience Clinic. Melilla.
• 2009-2017: Neurologist at the Melilla Hospital.
• 2008-2009: Neurologist at the Virgen de las Nieves Hospital. Granada.
• 2004-2008: Neurologist at the Carlos Haya Hospital. Malaga.
Academic Training:
• 2017: Innovation and Leadership in Neurology. Business Institute. Madrid.
• 2014: Educational Commission for Foreign Medical Graduates. United States.
• 2011-2012: Management of Integrated Health Services. ESADE. Madrid.
• 2010: Neurologists for the Future. Spanish Neurology Society.
• 2010: Master in Tissue Engineering. University of Granada.
• 2010: Doctorate at the University of Granada. Summa Cum Laude. 2010.
• 2004-2008: Neurology specialist at the Carlos Haya Hospital. Malaga.
• 1997-2003: University Graduate in Medicine at the University of Granada.
The Neurology Unit of the Quirónsalud Marbella Hospital specialises in the study and treatment of conditions associated to the nervous system, the brain, the spinal cord, the peripheral nerves and the muscles. We have the most advanced technology that enables us to make accurate and personalised diagnoses and treatments in the study of patients with complex diagnoses and treatments (MRI, CT scan,electroencephalogram, transacranial doppler ultrasound, cerebral arteriogramand neuropschycological testing).
We offer our patients highly-specialised treatments for cerebrovascular and neuromuscular diseases, Parkinson's Disease, headaches and migraine, epilepsy, multiple sclerosis, peripheral neuropathies, infections of the nervous system, movement disorders, dementia and other cognitive conditions, paediatric neurology, sleep disorders, tumours and complications deriving from injuries to the spine and the head.
Il medico è un neurologo di spicco in Germania, specializzato in ictus, sclerosi multipla, malattie reumatologiche e disturbi neurologici. <\/p>
Laureatosi all'Università di Heidelberg nel 1988, il medico ha proseguito la formazione post-laurea presso l'University College London e l'Università di Memphis. <\/p>
Attualmente, il medico dirige il Dipartimento di Neurologia presso la Clinica Nordwest e guida la sezione di Encefalite Virale della Società Tedesca di Neurologia. Inoltre, il medico serve come consulente regionale per il trattamento dell'ictus presso l'Istituto Robert Koch. <\/p>
Riconosciuto con numerose borse di studio e premi, incluso il premio della Fondazione Braun per metodi innovativi di trattamento della polmonite.<\/p>
Dr. Fatma Gulhan Sahbaz is a neurologist. She graduated from Manisa Celal Bayar University Faculty of Medicine. She completed her neurology residency at SBÜ Istanbul Kartal Dr. Lütfi Kırdar Training and Research Hospital. Dr. Sahbaz has served as Clinic Chief at Afyonkarahisar State Hospital. She currently practices at İzmir Ekonomi University Medical Point Hospital.
She treats many neurological conditions, including Alzheimer’s disease, ALS, epilepsy, cerebrovascular diseases, brain tumors, movement disorders, and headaches. Dr. Sahbaz is experienced in advanced treatments such as acute stroke intervention, deep brain stimulation, IVIG therapy, and botulinum toxin injections.
She is a member of the Turkish Neurology Society, International Parkinson and Movement Disorder Society, and European Academy of Neurology.
Il medico è un neurologo altamente esperto, focalizzato sulla diagnosi e il trattamento dei disturbi del sistema nervoso. Ha una vasta esperienza nella gestione di condizioni come epilessia, sclerosi multipla e malattia di Parkinson. Il medico è certificato in neurologia e ha contribuito a numerosi studi di ricerca sulle malattie neurodegenerative. Ha pubblicato diversi articoli sottoposti a revisione paritaria ed è attivamente coinvolto in studi clinici mirati a migliorare le opzioni di trattamento per i disturbi neurologici.<\/p>
EDUCATION:
2014 ADNAN MENDERES UNIVERSITY FACULTY OF MEDICINE, CHILD HEALTH AND DISEASES, CHILD NEUROLOGY
2011 IZMIR EDUCATION AND RESEARCH HOSPITAL, CHILD HEALTH AND DISEASES
2011 Izmir Tepecik Education and Research Hospital, Child Health and Diseases
2004 DICLE UNIVERSITY, FACULTY OF MEDICINE
EXPERIENCE:
2018 Istanbul Medipol Hospital
2017 - 2018 Kartal Education and Research Hospital
2014 - 2016 Denizli State Hospital
2011 - 2014 Aydin Adnan Menderes University Faculty of Medicine Hospital
2006 - 2011 Izmir Tepecik Education and Research Hospital
2011Izmir Education and Research Hospital
Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.
Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.
He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).
Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.
Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.
She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.
Somjet Tosamran, MD, is a neurologist. Dr. Tosamran is a fellow in epilepsy at the Neurology Division, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand (2024–present). Dr. Tosamran completed a neurology residency at the same hospital (2021–2024). Earlier training includes internships at Charoenkrung Pracharak Hospital and Sakaeo Crown Prince Hospital.
Accreditations and education: Neurologist certification, King Chulalongkorn Memorial Hospital (2024). Master of Science in Internal Medicine, Faculty of Medicine, Chulalongkorn University (2024). Doctor of Medicine, First Class Honors, Faculty of Medicine, Chulalongkorn University (2018).
Dr. Tara Rak-areekul is a neurologist focused on cognitive neurology. She is a fellow at King Chulalongkorn Memorial Hospital. She completed her neurology residency there and served as Chief of Academic in 2023. She holds an MD from Chulalongkorn University (Second Class Honors) and a Higher Graduate Diploma in Clinical Sciences. She is certified in NIHSS (2022) and the Thai Stroke Society Acute Stroke Treatment Course.
Key achievements include first rank in the National Formative Neurological Exam (2023). She won the Epilepsy Quiz Tournament (2023). She was first runner-up at the Neurology Tournaments at NST Midyear 2023 and the Chula Neuroscience Forum 2022. Her research includes AAIC poster presentations (2024, 2025). Ongoing work covers Alzheimer’s biomarkers (MDS‑OAβ and p‑tau217), the Thai clinical adaptation of HippoCamera, and a chapter on behavioral and psychological symptoms of dementia (BPSD).